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Abstract
Purpose of review
This review summarises the current evidence for the management for children
with recent upper respiratory tract infections. Furthermore, the review includes
management guidelines for children with upper respiratory tract infections.
Recent findings
Good history and clinical examination is sufficient in most children presenting
with URTI. Testing for immune markers or preoperative NO measurement does
not add any additional value. Preoperative bronchodilator administration, iv
induction with propofol and non-invasive airway management all reduce the
occurrence of respiratory adverse events.
Summary
Most children can be safely anaesthetised even in the presence of an upper
respiratory tract infection if the perioperative anaesthesia management is
optimised. In this review article we have included a management algorithm for
children with URTI presenting for elective surgery.

Keywords
Pediatric anesthesia, upper respiratory tract infections, respiratory adverse
events, anesthesia management.

Introduction
The common cold or upper respiratory tract infections (URTI) are frequently
present in children. Although URTI is commonly mild and self-limiting in nature, it
does place a burden on society due to the increased use of health care
resources and absences form work or school (1).
Performing anaesthesia in children with URTI increases the risk of perioperative
respiratory adverse events (PRAE, e.g. laryngospasm, bronchospasm,
desaturations, breath holding) (2–7).
The purpose of this review is to summarize current evidence regarding
perioperative anaesthetic management of children with an URTI.

Definition of URTI
Most studies define URTI as two of the following symptoms: rhinorrhoea, sore or
scratchy throat, sneezing, nasal congestion, malaise, cough, or fever > 38°(6, 7).
Prevalence / Incidence of URTI
While a child under the age of 4 has on average up to 8 URTI per year (1), the
incidence of URTI decreases with age with adults having on average 2 colds per
year (1). URTI occurrence is seasonal with increased emergence during the
colder months in the temperate and during the rainy season in the tropical
regions (1).
Between 25 and 45% of children presenting for elective surgery will have a
history of a recent URTI (7, 8); therefore, unsurprisingly, URTI is the most
common cause of surgery cancellation in children (9).

Most children with URTI have symptoms for around one week but these can
persist for up to three weeks (1).

While URTIs in children are most commonly caused by a viral infection (1),
bacterial superinfections are regularly found (1). Rhinovirus is by far (up to 80%)
the most frequent virus causing URTI in children (10). Other viruses include:
parainfluenza, respiratory syncytial, influenza, entero-, and, adeno-,
metapneumo-, and human boca virus (10). Testing for the infective agent is not
routinely performed in children with URTI as such results do not change
anaesthetic management. However, many experts acknowledge an RSV
infection as a more severe respiratory infection, which requires particular
attention and a careful risk benefit analysis before proceeding with anaesthesia
and surgery especially in infants (11).

Prevalence / Incidence of PRAE
The risk of PRAE is significantly increased in children with URTI (2–7, 12).
Children with a current and/or recent URTI experience between 24 and 30%
PRAE as opposed to children without URTI (8 to 17% PRAE) (5, 7). This is even
more pronounced in infants and those born prematurely (7).
Pathophysiology URTI
Symptoms depend on the anatomical location of the infected mucus membranes.
For example, the rhinovirus most often inoculates the nasal mucosa and will
cause a runny nose but can then spread to the throat and trachea whereas the
influenza virus has a predilection to the tracheobronchial epithelia (1).
Viral infection of the mucus membranes causes airway inflammation. Similar to
asthma, airway inflammation can lead to increased secretions, airway
susceptibility and bronchial hypersensitivity with increased risk of PRAE
predominantly laryngospasm and bronchospasm (13, 14).

In addition, some viruses can produce neuraminidase that inhibit M2 receptors
thereby increasing the release of acetylcholine (13). Furthermore, viral induced
liberation of tachykinin and neuropeptides have been described (13). Both
pathways increase the likelihood of bronchospasm.

Preoperative Assessment
Does the child have an URTI?
Hallmark of a cold is nasal discharge, sneezing, sore throat and cough (1). The
most frequent symptoms are rhinorrhoea (66%), followed by nasal congestion
(37%), sneezing (29%), productive cough (26%), sore throat (8%) and fever (8%)
(5). Bronchitis and tracheitis can cause dry cough and wheeze. Hoarse voice
indicates laryngitis. Non-specific symptoms including irritability, loss of appetite,
fatigue, muscle pain, headache. Fever is not uncommon in children (1).
Additional risk factors in children with URTI
Table 1
Several risk factors for the occurrence of PRAE in children with URTI have been
identified (13). These can be divided into patient factors, surgical factors and
anaesthetic management, see Table 1.
In children with URTI history of fever (RR 2.9), “green” instead of “clear runny
nose” (RR 3.2 and 1.4 respectively) or “moist” instead of “dry cough” (RR 3.2 and

1.8 respectively) are associated with increased risk of bronchospasm and
laryngospasm (7).

Lee et al have proposed a “COLDS” score to assess the risk of PRAE in children
with URTI presenting for elective surgery (15). The following parameters: current
symptoms, onset of symptoms, additional lung disease, planned airway type, and
planned surgery score 1, 2 or 5 points. Whilst this “COLDS” score has not been
validated the use of such a score might have some merit. The lowest overall
score will be 5 emphasizing that no anaesthesia in children with current or recent
URTI is without any risk. It is suggested that any category scoring the 5 should
be regarded as a red flag alerting the perioperative team of the increased risk of
PREA and allowing to team to modify the risk of the child where possible.

Preoperative management
Timing of procedure
There is much debate but no consensus regarding the optimal timing of elective
surgery in children with recent URTI. The duration of airway susceptibility and
bronchial hyper reactivity in children following a URTI remains unclear but is
known to persist well beyond resolution of symptoms. Given the high frequency
of URTI in children, this may make it difficult to find a time in which the child is
truly well.
There are no randomised controlled trials regarding best timing of general
anaesthesia in children with URTI (16).

Observational trials have the inherent selection bias with the sickest children
having their surgery postponed.
Most studies show that a current/recent URTI bare similar risk of PRAE (5, 7, 17).

There are only few studies examining the effect of different time points after URTI
on the occurrence of PRAE. One observational trial found that children with an
URTI < 2 weeks and 2 to 4 weeks had an increased risk of PRAE (OR 5.2 and
3.8 respectively) as opposed to children with an URTI 4 to 6 weeks prior surgery
(OR 0.2) (17). However, the sample size was small and inhomogeneous.
In the largest observational study to date, von Ungern-Sternberg et al found in
9297 children presenting for elective surgery that children with current and recent
URTI (<2 weeks) had more PRAE (25 and 29% respectively) than did children
without URTI or with URTI between 2 and 4 weeks (12 and 8% respectively) (7).

Some authors suggest that children with a mild URTI can be safely anesthetised
as the problems encountered are generally easily treated without long term
sequelae (9).

Whether a surgery should be cancelled should be a decision balancing risk and
benefit for each individual child including: patient and surgical risk factors of
developing PRAE, waste of public health care resources, previous surgery
cancellation, operation wait time, distance to travel for parents and difficulties for
parents to organise time off work.

Figure 1 depicts an algorithm to guide preoperative management in children with
URTI scheduled for elective surgery (9, 13).

In general, cancellation of children with URTI is only rarely necessary. While
some suggest more caution and to reschedule children with URTI, delaying
surgery by 4-6 weeks following each of the 6-8 URTI/year, severely restricts the
ideal surgical time frame and may lead to recurrent cancellations which again
impact negatively on the patient, his/her family as well as the health care system.
Furthermore, even when the URTI may be gone and airway hyperreactivity
reduced, the risk of PRAE is still present due to inherent conditions such as
wheezing or exposure to smoking. Therefore it is not surprising that the majority
of pediatric anaesthetists will still proceed with anesthesia even in the presence
of URTI (13, 18, 19). The right balance needs to be found between clinical
judgement of fitness for surgery and risk of PRAE linked to the presence of other
risk factors. When processing with anaesthesia and surgery, it is critical to
optimise the perioperative management to reduce the risk of PRAE.

Additional investigations
Good history and clinical examination is sufficient in most children presenting
with URTI. Testing for immune markers or preoperative NO measurement does
not additional value (20, 21). We do not routinely recommend any additional
investigations in children presenting with URTI for surgery.
If suspicion arises of the presence of undiagnosed asthma or a bacterial infection
(e.g. group A streptococcus tonsillitis) referral should be made to a specialist to
initiate appropriate investigations and treatment (e.g. antibiotics, bronchodilators,
steroid) (22). In children < 1 year of age, who are suspicious for RSV infection, a
rapid test may be considered (11).
Perioperative management
Table 2
Premedication

We do not recommend the use of benzodiazepine for premedication in children
with URTI as first line agents as this may be associated with increased PRAE (7,
17). Alpha-2 antagoinsts, e.g. clonidine, dexmedetomidin may be better suited if
premedication is required (22).
Lignocaine
We do not recommend the use of topical lignocaine to reduce the occurrence of
laryngospasm in children with URTI. An observational trial found topical
lignocaine to increase desaturation without reducing laryngospasms in children
with URTI (23).

In contrast, lignocaine gel placed on LMA reduced mainly postoperative coughing
in a small RCT of children with URTI (24). Although only short lived, IV lignocaine
has been shown to suppress the laryngospasm reflex in healthy children and
therefore may be useful in children with URTI (25).
Bronchodilators
We recommend preoperative salbutamol in children with current and recent (<2
weeks) URTI. A large prospective observational trial (n=600) showed salbutamol
inhaled 10 to 30 min prior induction (2.5 mg if weight <20 kg, 5 mg if weight >20
kg) to reduce overall PRAE mainly bronchospasm (6% vs 11%, P = 0.03) and
severe coughing (6% vs 12%, P = 0.03) (18).
In contrast, IV glycopyrolate after induction of anaesthesia does not reduce
PRAE in children with URTI (26).

Airway management
In children with URTI and an increased risk of PRAE we recommend the airway
management to be performed by an experienced paediatric anaesthetist as
multiple attempts and insertion by less experienced staff has been shown to
affect the incidence of PRAE (7).

The majority of observational studies and RCT show that endotracheal tubes
(ETT) are associated with the highest risk of PRAE compared with less invasive
airways (e.g. laryngeal mask airway (LMA) or face mask). The face mask is
associated with the smallest risk of PRAE in children with URTI (3, 5, 7, 8, 26, 27).
We therefore recommend the use of face mask or LMA over ETT where possible.
Small children in general and particularly those with URTI are prone to
experience PRAE (5, 7, 8, 28). A recent randomised controlled trial shows that
infants < 1 year especially benefit most from LMA over ETT in terms of
occurrence of PRAE (29). The rate of major PRAE (laryngospasm and
bronchospasm) is five fold increased with ETT compared with LMA (RR 5·30,
95% CI 1·62–17·35, p=0·002) when used for children undergoing minor elective
procedures (29). However, it has to be emphasised that using LMA in infants and

children with current or recent URTI reduces but does not abolish the occurrence
of PRAE (12). When using ETT in children with URTI we recommend the use of
cuffed over uncuffed ETT to improve ventilation and minimise leakage around the
tube (7).
In general, the risk of PRAE is higher on removal than on insertion of airway
devices (7, 26). Observational data suggests that deep removal of LMA or ETT
reduces the occurrence of PRAE (7). However, recent RCT reveal somewhat
conflicting results. Von Ungern-Sternberg et al compared the effect of deep vs
awake extubation of ETT in 100 children undergoing adeno-tonsillectomy (30).
The overall incidence of PRAE was similar between the two groups. Awake
extubation was associated with increased coughing (60 vs. 35%, P 0.03)
whereas airway obstructions (relieved by simple airway manoeuvres) were
increased following deep extubation (26 vs. 8%, P 0.03). In contrast, Baijal et al
did not find a difference in PRAE comparing deep vs awake extubation of ETT in
905 children undergoing adeno-tonsillectomy (28).

Unpublished data suggests that in children with URTI LMA deep removal may be
more beneficial than awake as deep removal as it is associated with reduced
desaturations and coughing.

Anaesthetic Agents
Propofol has good airway reflex (laryngospasm and bronchospasm) blunting
properties and is therefore the ideal agent to be used during the induction in
children with increased risk of PRAE (22, 31). Propofol does have some
bronchodilator effects but these are small in comparison to volatile anesthetic
agents.
Observational data in children with URTI as well as a large randomised
controlled trial in children at particular risk for PRAE (including those with URTI)
suggest that an IV propofol induction is associated with a significant reduction of
PRAE when compared with an inhalational induction with sevoflurane (8, 32).
Volatile anesthetic agents have good bronchodilator properties but limited effects
in suppressing airway reflexes (22). Volatile anaesthetic agents can be used to
treat severe bronchospasm or severe asthma.
When using volatile anesthetic agents for either induction or for maintenance we
recommend the use of sevoflurane (5, 7, 22). Sevoflurane has the best
bronchodilatatory effect of all currently available volatile anaesthetic agents.
On the contrary, desflurane is associated with a significantly increased risk for
PRAE due to its property to increase airway resistance and irritability and should
not be used in children particularly not in those with URTI (7, 22, 33).

The literature on the use of neuromuscular blocking agents in children with URTI
is scarce.

Intravenous vs inhalational induction
While a recent RCT comparing IV vs inhalational induction (32) demonstrated a
significant reduction in PRAE in children at a particularly high risk for PRAE
receiving an IV propofol induction, this included children with a variety of risk
factors including (but not exclusively) children with current or recent URTIs. While
Propofol is associated with a reduced occurrence of laryngospasm compared
with sevoflurane, cough and breath holding is increased (31).

Additionally, a recent study examining the effect of two concentrations of
sevoflurane for maintenance of anaesthesa (2.5%, MAC 1 vs 4.7%, MAC ED 95
Intubation) found that higher concentrations of sevoflurane did not protect against
the occurrence of laryngospasm (34). Laryngeal reflexes could still be found at a
BIS of 0 (34).
Overall we recommend an IV induction and maintenance with propofol over
inhalational induction for children with URTI to reduce the incidence of PRAE.

Conclusions
Most children can be safely anaesthetised even in the presence of an upper
respiratory tract infection if the perioperative anaesthesia management is
optimised. The detailed algorithm can be used as an aide to guide clinicians in
their everyday decision making.
Key points
• Children with current and recent (up to two weeks) URTI have an
increased risk of a perioperative respiratory adverse event (e.g.
laryngospasm, bronchospasm, desaturation, breath holding).
• In such children, the following risk factors further increase the risk for
PRAE: age < 2 years, prematurity, passive smoking, respiratory
comorbidities, airway surgery, and use of an ETT.
• In children with severe URTI (green runny nose, moist cough, wheezing,
fever, lethargy), we recommend to postpone surgery if possible for at least
two weeks.
• In order to reduce the risk of PRAE in children with current or recent URTI,
anaesthetic management can be optimised as follows: experienced staff
performing airway management, use of preoperative inhaled salbutamol,
IV induction with propofol, avoidance of desflurane, use of TIVA or
sevoflurane with a propofol or lignocaine bolus prior to any airway
manipulations.
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Table 1 - Risk factors for the occurrence of PRAE in children with URTI
(4–8, 12, 13)
Patient

Surgery

Anaesthetic management

-

copious secretions / presence of sputum
nasal congestion
paternal smoking / passive smoking
history of reactive airway disease,
younger age
prematurity (<37 weeks)
parental belief, “the child has is sick/a cold“
surgery of the airways
ear nose throat (ENT) surgery
eye surgery
upper abdominal surgery
cardiac surgery
invasive airway (endotracheal intubation)
anaesthetic agents (desflurane)
experience and compentence of the
anesthesiologist in pediatric anesthesia

Table 2 - Evidence based perioperative management of children with URTI
Premedication
- Avoid use of benzodiazepine for premedication (7, 17)
- Use of clonidine if premedication is required (22)

Lignocaine
- Consider IV lignocaine to suppress laryngospasm in high risk patient /
high risk procedure (25)
- Avoid topical lignocaine to vocal cords (23)
- Lignocaine gel on LMA may be beneficial to reduce postoperative
coughing (24)

Bronchodilators
- We recommend preoperative salbutamol (inhaled 10 to 30 min prior
induction, 2.5 mg if weight <20 kg, 5 mg if weight >20 kg) in children with
current and recent (<2 weeks) URTI (18)

Airway management
- We recommend the least invasive airway device (face mask over LMA
over ETT) (3, 5, 7, 8, 12, 26–28) (29).
- When using ETT we recommend where possible the use of uncuffed over
cuffed ETT tubes (7)
- Deep removal of LMA and ETT might reduce laryngospasm and PRAE but
is associated with increased airway obstructions (7, 28–30)
- We recommend airway control to be done by an experienced anaesthetist
in children with URTI at increased risk of PRAE (7)

Anaesthetic Agents
- Propofol has good airway reflex (laryngospasm and bronchospasm)
blunting properties but only mild bronchodilator effect (22, 31)
- Volatile anesthetic agents have good bronchodilator properties but limited
effects in suppressing airway reflexes (22)
- We recommend the use of volatile anaesthetic agents to treat severe
intraoperative bronchospasm
- We don’t recommend the use of volatile anaesthetic agents to treat severe
laryngospasm
- When using volatile anaesthetic agents sevoflurane is to be preferred over
other volatile anaesthetic agents (5, 7, 22)
- Desflurane should be avoided (7, 22, 33)
Intravenous vs inhalational induction
- In high risk children we recommend IV induction with propofol over
inhalational induction (8, 31, 32, 34)
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